Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives

Overview of attention for article published in Biomarker Research, August 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#16 of 388)
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 2 news outlets
twitter: 4 X users

patent: 2 patents

Citations

dimensions_citation: 130 Dimensions

Readers on

mendeley: 172 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 39,611 followers.

Resistance to #PD-1/PD-L1 blockade cancer #immunotherapy: mechanisms, predictive factors, and future perspectives Read full article: https://t.co/f18p180OPT

29 Jul 2021

Reply Repost Favourite

PD-1/PD-L1 blockade has been main target in cancer immunotherapy. However, only works in a minority of patients. There are other important immune checkpoints highly expressed like PVR, STING, CD73/80 or VISTA which could be targeted & deserve more rese

16 Jul 2021

Reply Repost Favourite

Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives https://t.co/bOoTYI6f4U

09 Apr 2021

Reply Repost Favourite

Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives https://t.co/bOoTYI6f4U

05 Sep 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.